State Key Laboratory for Manufacturing Systems Engineering; Electronic Materials Research Laboratory, Key Laboratory of the Ministry of Education, School of Electronic Science and Engineering, Xi’an ...
We provide an understanding of the development of epigenetic and transcriptomic Colorectal cancers (CRCs) subtypes that is rooted in altered TF expression. Our data reveal cancer-specific methylation ...
aDepartment of Epidemiology, Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht University, Utrecht, Netherlands bDepartment of Surgery, University Medical ...
aDepartment I of Internal Medicine and German CLL Study Group, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), University of Cologne ...
Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials Between January 2019 and ...
Patients with recent-onset atrial fibrillation commonly undergo immediate restoration of sinus rhythm by pharmacologic or electrical cardioversion. However, whether immediate restoration of sinus ...
As a great challenge in bioinformatics, enzyme function prediction is a significant step toward designing novel enzymes and diagnosing enzyme-related diseases. Existing studies mainly focus on the ...
Functional near-infrared spectroscopy (fNIRS) has evolved as a neuro-imaging modality over the course of the past two decades. The removal of superfluous information accompanying the optical signal, ...
† Single-Cell Center, CAS Key Laboratory of Biofuels and Shandong Key Laboratory of Energy Genetics, Qingdao Institute of Bioenergy and Bioprocess Technology, Chinese Academy of Sciences, Qingdao, ...
Delamanid (OPC-67683), a nitro-dihydro-imidazooxazole derivative, is a new antituberculosis medication that inhibits mycolic acid synthesis and has shown potent in vitro and in vivo activity against ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results